Hsbc Holdings PLC decreased its position in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 61.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 92,109 shares of the company's stock after selling 149,762 shares during the quarter. Hsbc Holdings PLC's holdings in UiPath were worth $939,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in the stock. Versant Capital Management Inc increased its position in shares of UiPath by 198.6% in the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after buying an additional 1,970 shares in the last quarter. CX Institutional bought a new position in UiPath during the 1st quarter worth about $36,000. Brooklyn Investment Group increased its holdings in UiPath by 314.3% during the 1st quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock worth $46,000 after purchasing an additional 3,420 shares in the last quarter. National Bank of Canada FI bought a new position in UiPath during the 1st quarter worth about $72,000. Finally, MRP Capital Investments LLC bought a new position in UiPath during the 1st quarter worth about $82,000. Institutional investors and hedge funds own 62.50% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. Zacks Research upgraded UiPath to a "hold" rating in a report on Friday, August 8th. DA Davidson upgraded UiPath to a "hold" rating in a report on Tuesday, July 22nd. Needham & Company LLC reiterated a "hold" rating on shares of UiPath in a report on Friday, May 30th. Truist Financial lifted their price target on UiPath from $12.00 to $13.00 and gave the stock a "hold" rating in a report on Friday, May 30th. Finally, Morgan Stanley lifted their price target on UiPath from $12.00 to $15.00 and gave the stock an "equal weight" rating in a report on Monday, June 2nd. Two equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $13.83.
View Our Latest Stock Report on PATH
UiPath Stock Performance
Shares of PATH stock traded down $0.21 during trading on Tuesday, hitting $10.92. The company had a trading volume of 11,388,538 shares, compared to its average volume of 8,998,580. The firm has a market capitalization of $5.84 billion, a P/E ratio of -90.95, a price-to-earnings-growth ratio of 14.57 and a beta of 1.02. The stock's 50-day moving average price is $11.85 and its 200 day moving average price is $11.90. UiPath, Inc. has a one year low of $9.38 and a one year high of $15.93.
Insider Activity
In other UiPath news, CEO Daniel Dines sold 9,988 shares of the business's stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $12.00, for a total transaction of $119,856.00. Following the completion of the transaction, the chief executive officer directly owned 4,598,388 shares in the company, valued at $55,180,656. The trade was a 0.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders sold 831,310 shares of company stock valued at $10,428,922 in the last three months. Insiders own 23.19% of the company's stock.
UiPath Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.